 |
|
 |
 |
We provide clients with toxicology and product safety assessment guidance through preclinical and clinical testing.
Our clients are also interested in acquiring preclinical safety and toxicology information. This information potentially leads to product commercialization or acquisition.
We work with clients in the evaluation
and interpretation of the safety of:
- Existing and potential products
- Metabolites
- Degradants
- Impurities
- Intermediates
- Product acquisitions
- Larger molecules that have been made nano-sized
We have considerable experience with the safety assessment of small and large molecules, nanoparticles and nanomaterials, as well as botanicals.
Additional services that we provide include:
- Toxicology summaries may be prepared for potential products. These
summaries can be used as part of a clinical protocol submitted to an
Institutional Review Board (IRB), for inclusion in Investigator's Brochures
(IB) and for regulatory submissions, in addition to management and investor
presentations.
- Scientific literature searches, review toxicology literature, publications
(public and internal documentation) and toxicology study data
- Generation of position or white papers, study reports, and manuscripts
or abstracts for internal purposes, publications and for litigation support.
- Peer review of study reports, toxicology or related papers, manuscripts,
submissions, etc.
- Document review and Quality Assurance reviews
- Evaluation of the safety of products obtained through manufacturing
process changes
- Review license candidates and perform due diligence audits
|
Home | Services | GLP Consulting | Toxicology Consulting | Background | Contact
GLP Training Division |
|
| |
|
|